SciELO - Scientific Electronic Library Online

 
vol.41Initial experience of percutaneous coronary revascularization through transradial access at the Institute of Cardiology and Cardiovascular SurgeryResilient coping and future expectations in university students in Peru during the pandemic author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Investigaciones Biomédicas

On-line version ISSN 1561-3011

Abstract

VASALLO PERAZA, Román et al. Management of mitral stenosis during pregnancy. Rev Cubana Invest Bioméd [online]. 2022, vol.41  Epub Aug 29, 2022. ISSN 1561-3011.

Heart disease complicates about 4% of pregnancies; and represent the leading non-obstetric cause of maternal death. Valvular lesions have a high prevalence, being mitral stenosis the one with the worst prognosis during pregnancy. This article aims to present the recommendations of the National Heart Disease and Pregnancy Service for the management of mitral stenosis during pregnancy. Evaluation of valve anatomy and disease severity is crucial. Moderate to severe injuries should be treated with cardioselective beta-blockers and elective percutaneous commissurotomy, if the anatomy is favorable. If there is volume retention, diuretics are indicated. Among the drugs for obstetric use, prostaglandins, nifedipine and fenoterol are contraindicated. The time of termination of pregnancy depends on the gestational age and the appearance of signs of maternal or fetal decompensation, in which case they have an indication for cesarean section.

Keywords : mitral stenosis; pregnancy.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )